Results 1 to 10 of about 20,056 (331)

Transjugular intrahepatic portosystemic stent-shunts: a new option in portal hypertension. [PDF]

Gut, 2020
These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under
Armstrong, Matthew J, Aspinall, Richard J, Hayes, Peter C, Ireland, Hamish, Leithead, Joanne A, Lomax, Mandy, McDonagh, Joanne, Mehrzad, Homoyon, Patch, David, Roslund, Nicholas, Rowe, Ian A, Stanley, Adrian J, Travis, Simon, Tripathi, Dhiraj, Tsochatzis, Emmanuel A   +14 more
core   +4 more sources

Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices [PDF]

Korean Journal of Radiology, 2017
OBJECTIVE: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term outcomes from these
Kim, Seung Kwon, Korenblat, Kevin, Lee, Kristen A, Sauk, Steven   +3 more
core   +4 more sources

Transjugular intrahepatic portosystemic shunts: An update [PDF]

Liver Transplantation, 2003
Transjugular intrahepatic portosystemic shunts (TIPS) have been used in the treatment of complications of portal hypertension. TIPS is used for the control of acute variceal bleeding and for the prevention of vericeal rebleeding when pharmacologic therapy and endoscopic therapy have failed. Patients with refractory ascites with adequate hepatic reserve
Belén Rosado
openalex   +4 more sources

Shunt porto-sistémico intra-hepático transjugular.

Acta Médica Portuguesa, 1994
The case of a 66-year-old woman with several episodes of hemorrhage by esophageal varices and ascites due to portal hypertension is presented. Despite 4 sessions of endoscopic sclerotherapy bleeding recurred.
J M Pisco, J M Martins, V Garcia, M G Correia, M L Figueiredo, N Jalles, J M Freitas, F C Leal   +7 more
doaj   +4 more sources

Transjugular intrahepatic portosystemic shunt.

Clinical privilege white paper, 2020
The transjugular intrahepatic portosystemic shunt (TIPS) is a percutaneous procedure designed to decompress the portal system in patients with portal hypertension. TIPS is indicated as prophylaxis for recurrent variceal bleeding, refractory active variceal bleeding, and refractory ascites or hepatic hydrothorax.
J. Palmaz
semanticscholar   +3 more sources

Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension [PDF]

Insights into Imaging
Objectives Transjugular intrahepatic portosystemic shunt (TIPS) is a catheter-based, minimally invasive procedure to reduce portal hypertension. The aim of the study was to investigate dysfunction and mortality after TIPS and to identify factors ...
Laura Büttner, Lisa Pick, Martin Jonczyk, Uli Fehrenbach, Federico Collettini, Timo Alexander Auer, Dirk Schnapauff, Maximilian De Bucourt, Gero Wieners, Bernhard Gebauer, Annette Aigner, Georg Böning   +11 more
doaj   +2 more sources

Transjugular intrahepatic portosystemic shunt for esophagojejunal variceal bleeding after total gastrectomy: A case report [PDF]

Radiology Case Reports
Esophagojejunal varices occurring after total gastrectomy are rare but potentially fatal in cases of variceal bleeding. Owing to their rarity, treatment strategies for this condition are not well established.
Sang Un Kim, MD, Jihoon Hong, MD
doaj   +2 more sources

The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis. [PDF]

J Clin Med
The development and progression of ascites represent a crucial event in the natural history of patients with cirrhosis, predisposing them to other complications and carrying a heavy impact on prognosis.
Iannone G, Pompili E, De Venuto C, Pratelli D, Tedesco G, Baldassarre M, Caraceni P, Zaccherini G.   +7 more
europepmc   +3 more sources

Outcome of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Refractory Hepatic Hydrothorax: A Systematic Review and Meta-analysis [PDF]

Indian Journal of Radiology and Imaging
Background Around 5% of patients with cirrhosis of the liver develop hepatic hydrothorax (HH). For patients with refractory HH (RHH), transjugular intrahepatic portosystemic shunt (TIPS) has been investigated in small studies.
Suprabhat Giri, Ranjan Kumar Patel, Taraprasad Tripathy, Mansi Chaudhary, Prajna Anirvan, Swati Chauhan, Mitali Madhumita Rath, Manas Kumar Panigrahi   +7 more
doaj   +2 more sources

North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. [PDF]

, 2022
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and mortality.
Abraldes, Juan, Allegretti, Andrew, Asrani, Sumeet, Bajaj, Jasmohan, Biggins, Scott, Boike, Justin, Darcy, Michael, Fallon, Michael, Farr, Maryjane, Farsad, Khashayar, Fortune, Brett, Garcia-Tsao, Guadalupe, Hall, Shelley, Izzy, Manhal, Jadlowiec, Caroline, Kolli, K, Krowka, Michael, Laberge, Jeanne, Lee, Edward, Mulligan, David, Nadim, Mitra, Northup, Patrick, Salem, Riad, Shatzel, Joseph, Shaw, Cathryn, Simonetto, Douglas, Susman, Jonathan, Thornburg, Bartley, VanWagner, Lisa, Verna, Elizabeth   +29 more
core   +4 more sources